Empiece
AbbVie Inc.AbbVie Inc.AbbVie Inc.

AbbVie Inc.

No hay operaciones
Ver en los supergráficos
Resumen Información financiera Noticias Ideas Debates Datos técnicos Previsión Estacionales Opciones
Bonos

Bonos de ABBV

A continuación, encontrará la lista de bonos de corporativos AbbVie Inc.. Los inversores suelen optar por los bonos de empresa debido a su mayor estabilidad en tiempos de volatilidad del mercado. Estudie los precios, los rendimientos y otras estadísticas para encontrar una inversión fiable.
Símbolo
YTM %
Volumen
Precio %
Cupón %
Fecha de vencimiento
Imp. pendiente
Valor nominal
Imp. mín. denom.
Emisor
AA5QDALLERGAN FNDG 15/25
7,45%098,90%3,80%2025-03-15130,22 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
7,40%15 K79,63%4,85%2044-06-1565,23 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,28%10 K79,20%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
7,17%600 K84,44%4,55%2035-03-15107,65 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
7,06%5 K80,72%4,63%2042-10-0167,49 M USD1.000,00 USD2.000,00 USDActavis, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
6,00%50 K89,00%3,20%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9ABBVIE 16/46
5,92%086,12%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,89%14,54 M83,38%4,25%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
5,82%089,50%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,76%325 K90,03%4,63%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,73%6,67 M88,21%4,40%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,71%410 K92,08%4,85%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,70%220 K91,08%4,75%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,69%1,74 M91,72%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,66%13,19 M86,93%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,64%4,74 M98,26%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,51%3,26 M98,76%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
5,48%091,67%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
5,47%099,14%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,46%8,11 M99,01%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
5,34%094,36%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
5,25%887 K95,33%4,55%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
5,08%23,22 M99,78%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,98%60,08 M92,86%3,20%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,95%26,49 M100,00%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,79%4,03 M99,70%3,80%2025-03-152,89 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,79%27,49 M100,05%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,74%097,88%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
4,71%10,28 M96,79%2,95%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
4,67%3,85 M98,60%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
4,62%11,49 M100,38%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
4,13%092,36%2,13%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
XS190919331ALLERGAN FNDG 18/28
4,09%095,00%2,63%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
3,86%096,53%2,95%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
3,03%089,73%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
3,01%0102,15%3,80%2025-03-151,27 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
2,90%0121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
2,88%0126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,83%0128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591491ABBVIE 20/29
2,79%097,33%2,13%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,76%097,71%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,73%099,64%2,63%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,52%095,07%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,35%0123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
———3,80%2025-03-15—1.000,00 USD2.000,00 USDAbbVie, Inc.